Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT07506161
Radiofrequency Ablation Treatment of Low-Risk Papillary Thyroid Carcinomas
Sponsor: Premier G Med Cardio Kft
View on ClinicalTrials.gov
Summary
Researchers in this study aim to prove the safety and efficacy of radiofrequency ablation in the treatment of a carefully selected low-risk papillary thyroid microcarcinoma patient group.
Official title: Thermoablation Treatment of Malignant Thyroid Carcinomas
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
27
Start Date
2021-09-09
Completion Date
2025-12-31
Last Updated
2026-06-09
Healthy Volunteers
No
Conditions
Interventions
PROCEDURE
Radiofrequency ablation alone
Ultrasound-guided percutaneous radiofrequency ablation of T1N0M0 papillary thyroid microcarcinomas
Locations (1)
Premier Med Egészségügyi- Oktató- és Kutatóintézet
Budapest, Hungary